secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2026-04-15T23:59:59+00:00
Accession:  0001493152-26-016683
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspire Biopharma signs LOI to acquire Driver Controls Systems unit for $30M
---------------------------------------------------------------------------

- Entered non-binding LOI to acquire Driver Controls Systems business unit of Firefish Topco for $30M cash-free, debt-free.
- Purchase price payable in cash at closing; no new equity raise anticipated.
- Break-up fees of $3.5M applicable under certain circumstances; 30-day no-shop period.
- Company plans to engage Lakewood & Company for management services post-closing.
- Acquisition subject to definitive agreement; LOI non-binding except for exclusivity, confidentiality, and break-up fees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226016683/0001493152-26-016683-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226016683/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-016683

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer